Identifying few but key genetic and epigenetic changes in both cancer stem-like cells (or CSCs) and other tumor parenchymal cells of each specific cancer patient, such as MYC amplification in patient P2 or MGA mutation in patient P7 in this study, could help design more effective methods to treat human cancer in the future. This evidence concerns the gene MYC and cancer.